Redeye Feed

2025-05-30 13:19:00 AcouSort Q1 - In line with estimates

2025-05-30 11:39:00 Saniona Q1 - More deals on the menu

2025-05-30 11:37:00 Sprint Bioscience - Increased pressure ahead of the next sprint baton-exchange

2025-05-30 11:36:00 Verve Group - Increased market uncertainty

2025-05-30 11:35:00 MindArk - Continued investing yet to shine through to sales

2025-05-28 10:59:00 FluoGuide Q1 2025 - Phase II HNC readout around the corner

2025-05-28 10:20:00 Elicera Therapeutics Q1 - Positive pattern emerging in CARMA trial

2025-05-28 10:19:00 SynAct Pharma Q1 2025 - New Phase II Study in Dengue Fever

2025-05-27 08:39:00 Kancera Q1 - Continued efforts with Recardio

2025-05-27 08:38:00 Embracer - Soft near-term outlook, solid longer-term pipeline

2025-05-27 08:36:00 Lipigon Q1 2025 - 64.5% Subscription Rate in the Rights Issue

2025-05-26 20:50:00 Vertiseit - Summit Season

2025-05-26 20:49:00 Jumpgate - All eyes to the upcoming quarters

2025-05-26 11:32:00 Better Collective - Improved visibility

2025-05-26 11:31:00 CTEK - A CMD that underpins the new financial targets

2025-05-22 13:01:00 Camurus Q1 2025 - Buvidal On Target, Brixadi Flat

2025-05-22 12:59:00 Neola Medical Q1 - Clinical progress on track

2025-05-22 12:58:00 Flexion Mobile - Solid report with no surprises

2025-05-21 11:02:00 Oncopeptides Q1 2025 - Strong Q/Q Growth with Japan the Next Catalyst

2025-05-21 10:59:00 Lagercrantz - Twin engines working in tandem

2025-05-20 22:30:00 Cinclus Pharma Q1 - Focus on upcoming pivotal study

2025-05-20 22:29:00 Scibase Q1 - Laying the groundwork for US expansion

2025-05-19 13:21:00 Ascelia Pharma update - Funded for near-term triggers ahead

2025-05-19 13:19:00 CLS Q1 - A solid quarter largely in line with our expectations

2025-05-19 13:18:00 Paxman Q1 - Softer quarter than expected, but CIPN adds long-term value

2025-05-19 13:17:00 Dala Energi - Steady she goes

2025-05-19 13:16:00 Lytix Biopharma Q1 2025 - Progress in NeoLIPA but Financial Weakness for Verrica

2025-05-19 13:15:00 Safello - Charts course through crypto volatility

2025-05-16 09:26:00 EG7 - Solid growth in Q1 and continued potential ahead

2025-05-16 09:24:00 Thunderful Group - One step in the right direction

2025-05-16 09:22:00 Fable Media Group - Unlocking additional cash flow

2025-05-16 09:21:00 Navigo Q1 2025 - Solid prospects despite softer quarter

2025-05-15 11:35:00 OncoZenge Q1 - Pieces falling into place

2025-05-15 11:34:00 Alzinova Q1 - Extended financial runway

2025-05-15 11:32:00 Surgical Science Q1 2025 - Everything and the kitchen sink

2025-05-15 11:31:00 SenzaGen Q1 - Quarterly sales impacted by challenging market climate

2025-05-15 11:30:00 Gentoo Media - Temporary setback

2025-05-14 11:17:00 Moberg Pharma Q1 - In the midst of the high season

2025-05-14 11:15:00 Acarix Q1 - Strong foundation for eventual ramp-up

2025-05-14 11:14:00 Starbreeze - Benefit from independence

2025-05-14 11:13:00 Cantargia Q1 2025 - Approaching Crucial TRIFOUR Readout

2025-05-14 11:11:00 Nekkar - Q1 Review – Short-Term Softness, Fundamentals Intact

2025-05-14 11:10:00 CoinShares - Solid profitability overshadowed by end-of-period AUM

2025-05-14 11:09:00 Smart Eye - Next station – Positive EBITDA

2025-05-13 10:33:00 Kontigo Care - Transitioning to a MedTech product platform company

2025-05-12 10:28:00 CombinedX - Acquiring a high-performing Norwegian IFS partner

2025-05-12 10:27:00 RaySearch Laboratories Q1 - Demonstrating a strong profitability outlook

2025-05-12 10:26:00 Initiator Pharma Q1 - Slow and steady

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden